Ute Boronowsky

The role of biostatisticians goes far beyond analyzing data at the end of a clinical study. Instead, they should be involved in clinical trial management right from the start to maximize the chances for a new drug’s market approval. Biostatisticians in clinical trial management have a long to-do list. They advise on study design, calculate […]

The success of a new drug depends on much more than its efficacy and safety or the ingenuity of its developers. Each clinical trial has multiple decision points, and taking the wrong turn at any of these can put the entire project at risk. Data management, fully integrated into the clinical study, is a cornerstone […]